2022 Annual Meeting | S30 - Autonomic Disorders
Program Materials Program Evaluations
| 03:30 PM - 03:42 PM PDT | Speaker |
2022 Irwin Schatz Award for Autonomic Disorders: This award recognizes young investigators who have advanced the field of autonomic disorders, or senior investigators who have made major contributions to the field.
Eduardo E. Benarroch, MD, FAAN |
| 03:30 PM - 03:30 PM PDT | Speaker |
Walk-in Slides
Eduardo E. Benarroch, MD, FAAN |
| 03:42 PM - 03:54 PM PDT | Abstract |
002 - Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure
Wolfgang Singer, MD |
| Phillip A. Low, MD, FAAN | Dr. Low has nothing to disclose. |
| No disclosure on file | |
| Tonette Gehrking | Tonette Gehrking has nothing to disclose. |
| Jade Gehrking | Jade Gehrking has nothing to disclose. |
| David M. Sletten, MBA | Mr. Sletten has nothing to disclose. |
| Wolfgang Singer, MD | Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care. |
| Mohammad Shahnawaz, PhD | The institution of Dr. Shahnawaz has received research support from American Parkinson Disease Association. The institution of Dr. Shahnawaz has received research support from NIH. The institution of Dr. Shahnawaz has received research support from Texas Alzheimer's Research & Care Consortium . Dr. Shahnawaz has received intellectual property interests from a discovery or technology relating to health care. |
| Ann M. Schmeichel | Ann M. Schmeichel has nothing to disclose. |
| Claudio Soto | Claudio Soto has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amprion. Claudio Soto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rinri therapeutics. Claudio Soto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affyxell Therapeutics. Claudio Soto has stock in Amprion. The institution of Claudio Soto has received research support from NIH. The institution of Claudio Soto has received research support from Michael J. Fox Foundation. The institution of an immediate family member of Claudio Soto has received research support from NIH. Claudio Soto has received intellectual property interests from a discovery or technology relating to health care. |
| Mariana Suarez | No disclosure on file |
| Eduardo E. Benarroch, MD, FAAN | Dr. Benarroch has nothing to disclose. |
| Elizabeth A. Coon, MD, FAAN | Dr. Coon has nothing to disclose. |
| Melissa M. Cortez, DO | Dr. Cortez has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PCARES.org. The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Amgen Independent Investigator Award. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project. |